Corneal collagen crosslinking
SCHWIND eye-tech-solutions says the company is the first and only manufacturer of excimer laser systems to offer the integrated SCHWIND CXL-365 vario system for corneal collagen crosslinking (CXL). 'CXL using ultraviolet A (UVA) light and riboflavin (vitamin B2) was introduced as a clinical application to stabilise the cornea by inducing crosslinks within and between collagen fibres. CXL has been investigated extensively and has been shown clinically not only to arrest the progression of keratoconic or post-LASIK ectasia but also to exert a moderately positive effect on visual status,' said a company spokeswoman.
Latest Articles
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.
AI Analysis and the Cornea
A combination of better imaging and AI deep learning could significantly improve corneal imaging and diagnosis.
Cooking a Feast for the Eyes
A cookbook to promote ocular health through thoughtful and traditional cuisine.
Need to Know: Spherical Aberration
Part three of this series examines spherical aberration and its influence on higher-order aberrations.
Generating AI’s Potential
How generative AI impacts medicine, society, and the environment.